An unexpected plasma cholinesterase activity rebound after challenge with a high dose of the nerve agent VX

Toxicology

Volumn 248, Issue 2-3, 2008, Pages 151-157

  Dorandeu, F ^a   Foquin, A ^a   Briot, R ^b   Delacour, C ^a   Denis, J ^a   Alonso, A ^a   Froment, M T ^a   Renault, F ^a   Lallement, G ^a   Masson, P ^a  

^a CENTRE DE RECHERCHES   (France)

^b HÔPITAL MICHALLON   (France)

Author keywords

Cholinesterase rebound; Nerve agent; Swine; VX

Indexed keywords

5,5' DITHIOBIS(2 NITROBENZOIC ACID); ARYLDIALKYLPHOSPHATASE; CARBOXYLESTERASE; CHOLINESTERASE; ESTERASE; METHYLPHOSPHONOTHIOIC ACID S (2 DIISOPROPYLAMINOETHYL) O ETHYL ESTER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOLYSIS; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME INHIBITION; ENZYME REACTIVATION; ENZYME SYNTHESIS; LIVER CYTOSOL; MALE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BUTYRYLCHOLINESTERASE; CHEMICAL WARFARE AGENTS; CHOLINESTERASE INHIBITORS; CHOLINESTERASES; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAVENOUS; MALE; ORGANOTHIOPHOSPHORUS COMPOUNDS; PULMONARY EDEMA; SWINE;

CANIS FAMILIARIS; SUIDAE;

EID: 44149083019     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2008.03.013     Document Type: Article

References (29)

1. Aurbek N., Thiermann H., Szinicz L., Eyer P., and Worek F. Analysis of inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds with human and pig acetylcholinesterase. Toxicology 224 (2006) 91-99
2. Bajgar J., Kuca K., Fusek J., Karasova J., Kassa J., Cabal J., Jun D., and Blaha V. Inhibition of blood cholinesterases following intoxication with VX and its derivatives. J. Appl. Toxicol. 27 (2007) 458-463
3. Brown S.S., Kalow W., Pilz W., Whittaker M., and Woronick C.L. The plasma cholinesterases: a new perspective. Adv. Clin. Chem. 22 (1981) 1-123
4. Chilcott R.P., Dalton C.H., Hill I., Davidson C.M., Blohm K.L., and Hamilton M.G. Clinical manifestations of VX poisoning following percutaneous exposure in the domestic white pig. Hum. Exp. Toxicol. 22 (2003) 255-261
5. Chilcott R.P., Dalton C.H., Hill I., Davison C.M., Blohm K.L., Clarkson E.D., and Hamilton M.G. In vivo skin absorption and distribution of the nerve agent VX (O-ethyl-S-[2(diisopropylamino)ethyl] methylphosphonothioate) in the domestic white pig. Hum. Exp. Toxicol. 24 (2005) 347-352
6. Conn, L.W., Wiles, J.S., Horton, R.G. (1957). Preliminary toxicological studies of EA 1701 (Report CWLR 2134).
7. Dave K.R., and Katyare S.S. Effect of alloxan-induced diabetes on serum and cardiac butyrylcholinesterases in the rat. J. Endocrinol. 175 (2002) 241-250
8. Delaunois A., Gustin P., and Ansay M. Altered capillary filtration coefficient in parathion- and paraoxon-induced edema in isolated and perfused rabbit lungs. Toxicol. Appl. Pharmacol. 116 (1992) 161-169
9. Dorandeu F., Mikler J.R., Thiermann H., Tenn C., Davidson C., Sawyer T.W., Lallement G., and Worek F. Swine models in the design of more effective medical countermeasures against organophosphorus poisoning. Toxicology 233 (2007) 128-144
10. Ellman G.L., Courney K.D., Andres V., and Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7 (1961) 88-95
11. Fujikawa Y., Satoh T., Suganuma A., Suzuki S., Niikura Y., Yui S., and Yamaura Y. Extremely sensitive biomarker of acute organophosphorus insecticide exposure. Hum. Exp. Toxicol. 24 (2005) 333-336
12. Furlong C.E., Richter R.J., Chapline C., and Crabb J.W. Purification of rabbit and human serum paraoxonase. Biochemistry 30 (1991) 10133-10140
13. Genovese R.F., Benton B.J., Lee E.H., Shippee S.J., and Jakubowski E.M. Behavioral and biochemical evaluation of sub-lethal inhalation exposure to VX in rats. Toxicology 232 (2007) 109-118
14. Göransson-Nyberg A., Fredriksson S.A., Karlsson B., Lundstrom M., and Cassel G. Toxicokinetics of soman in cerebrospinal fluid and blood of anaesthetized pigs. Arch. Toxicol. 72 (1998) 459-467
15. Hulet, S.W., Sommerville, D.R., Matson, K.L., Crouse, C.L., Scotto, J.A., Benton, B.J., Mioduszewski, R.J., Thomson, S.A., 2007. Estimating miotic, severe and lethal toxic effects in Gottingen minipigs following inhalation, intravenous and subcutaneous exposures to VX. HFM-149 RTO SYMPOSIUM Defense against the effects of chemical hazards: toxicology, diagnosis, and medical countermeasures.
16. Jbilo O., L'Hermite Y., Talesa V., Toutant J.P., and Chatonnet A. Acetylcholinesterase and butyrylcholinesterase expression in adult rabbit tissues and during development. Eur. J. Biochem. 225 (1994) 115-124
17. Kalman J., Juhasz A., Janka Z., Rakonczay Z., Abraham G., Boda K., Farkas T., and Penke B. Serum butyrylcholinesterase activity in hyperlipidaemia. Atherosclerosis 173 (2004) 145-146
18. Kalman J., Juhasz A., Rakonczay Z., Abraham G., Zana M., Boda K., Farkas T., Penke B., and Janka Z. Increased serum butyrylcholinesterase activity in type IIb hyperlipidaemic patients. Life Sci. 75 (2004) 1195-1204
19. Karnovsky M.J., and Roots L. A "Direct-Coloring" thiocholine method for cholinesterases. J. Histochem. Cytochem. 12 (1964) 219-221
20. Khoury G.F., Brill J., Walts L., and Busuttil R.W. Atypical serum cholinesterase eliminated by orthotopic liver transplantation. Anesthesiology 67 (1987) 273-274
21. Kimura, K.K., McNamara, B.P., Sim, V.M. (1960). Intravenous administration of VX in man. U.S. Army Chemical Corps Research and Development Command. Report CRDLR 3017.
22. Lainee P., Robineau P., Guittin P., Coq H., and Benchetrit G. Mechanisms of pulmonary edema induced by an organophosphorus compound in anesthetized dogs. Fundam. Appl. Toxicol. 17 (1991) 177-185
23. Li B., Sedlacek M., Manoharan I., Boopathy R., Duysen E.G., Masson P., and Lockridge O. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma. Biochem. Pharmacol. 70 (2005) 1673-1684
24. Naguib M., Gomaa M., Samarkandi A.H., Bevan D.R., Akkielah A.K., Watson C., Billecke S., and La Du Jr. B.N. Increased plasma cholinesterase activity and mivacurium resistance: report of a family. Anesth. Analg. 89 (1999) 1579-1582
25. Nambiar M.P., Gordon R.K., Rezk P.E., Katos A.M., Wajda N.A., Moran T.S., Steele K.E., Doctor B.P., and Sciuto A.M. Medical countermeasure against respiratory toxicity and acute lung injury following inhalation exposure to chemical warfare nerve agent VX. Toxicol. Appl. Pharmacol. 219 (2007) 142-150
26. Niven A.S., and Roop S.A. Inhalational exposure to nerve agents. Respir. Care Clin. N. Am. 10 (2004) 59-74
27. Sidell F.R., and Groff W.A. The reactivatibility of cholinesterase inhibited by VX and sarin in man. Toxicol. Appl. Pharmacol. 27 (1974) 241-252
28. van der Schans M.J., Lander B.J., van der Wiel H., Langenberg J.P., and Benschop H.P. Toxicokinetics of the nerve agent (+/-)-VX in anesthetized and atropinized hairless guinea pigs and marmosets after intravenous and percutaneous administration. Toxicol. Appl. Pharmacol. 191 (2003) 48-62
29. Yanagisawa N., Morita H., and Nakajima T. Sarin experiences in Japan: acute toxicity and long-term effects. J. Neurol. Sci. 249 (2006) 76-85